Related by context. Frequent words. (Click for all words.) 70 GlaxoSmithKline Novartis 66 GlaxoSmithKline Bristol Myers 61 GlaxoSmithKline AstraZeneca 60 AstraZeneca GlaxoSmithKline 60 Idec Roche 58 Wyeth Pharmaceuticals Wyeth 57 Inc Therapeutic Competitors 57 Stocks Advance Paced 56 Vytorin combines 56 unique PER.C6 ® 56 Samsung Sony Ericsson 56 Presents Positive 56 Earnings Scorecard 55 Bearish Pressure Building 55 PROFILE CO 55 Signs Licensing Agreement 54 Bayer HealthCare subsidiary 54 Markets Examine 54 Q2 Profit Surges 54 Signs Agreements 54 Bearish Moving Average 54 Completes Enrollment 54 Tata Motors Tata Steel 54 3Q Profits 54 Medtronic Novartis Biogen 53 Tata Steel Tata Motors 53 Lockheed Martin Northrop Grumman 53 Chevron ConocoPhillips 53 Profit Beats Estimates 53 Merck Serono Novartis 53 FDA Warns 53 Q3 Profit Surges 53 3Q Profit Rises 53 Quarterly Profit Rises 53 quotes/comstock/# * 53 2Q Profits 52 4Q Profits 52 Co MRK 52 Zacks Analyst Interview 52 Director Exercises Options 52 Movers Roundup 52 GlaxoSmithkline 52 Bullish Moving Average 52 Companies Mentioned 52 Bristol Meyers Squibb 52 FREE Whitepaper 52 Calls Purchased 52 Announce Collaboration 52 4Q Profit Jumps 52 www.gsk.com 52 2Q Profit Up 52 Lowers Guidance 52 Raises Outlook 52 GSK Pharma 52 Glaxo Smithkline 51 Novartis NOVN.VX 51 3Q Profit Up 51 Q4 Profit Surges 51 Nasdaq AMGN 51 Expand Relationship 51 Patent Covering 51 Q1 Profit Rises 51 Toyota Renault Nissan 51 Q2 Profit Declines 51 Citrix EDS 51 Q2 Profit Rises 51 Posts Strong 50 Profit Soars 50 Inc. FY# Q3 50 Sees Profit 50 4Q Profit Falls 50 Detects Unusual Activity 50 Options Brief 50 Target Radio Shack 50 Options Trader Alert 50 2Q Profit Rises 50 include Kenmore Craftsman 50 Drug Candidate 50 FY# Q3 earnings 50 FDA Accepts 50 Inks Pact 50 Zacks Analyst Blog Highlights 50 Q1 Loss Widens 50 Stockholders Approve Merger 50 Announces Presentation 50 Finalizes Acquisition 50 Q3 Profit Rises 50 Sanofi Aventis SASY.PA 50 R Wella 50 Lipitor Zocor 50 Glaxosmithkline 50 Equipment Deals 50 Updates Outlooks 50 Pfizer PFE.N 50 Trend Continues Down 50 PriceWatch Alert Technicals Showing 50 CEO Exercises Options 50 Acquire Stake 50 Q3 Loss Narrows 50 Report Examines 50 Analyst Expectations